For instance, AMPK is reported to be involved in the regulation of nonalcoholic fatty liver disease [39], ischemic stroke-induced brain injury [40, 41], acute lung injury [42], and OA progression [43]. Here, PRKAA1 is linked to metabolic dysfunction-associated steatotic liver disease.